Evidence map›Paper›PMID 37953251›Full record

ArticleBMC women's health2023

Case series of ovarian neuroendocrine carcinoma: overview of clinicopathological features.

Bao-Jie Feng, Tian-Hua Li, Yue-Hong Li, Jing-Xuan Feng, Jun Zhang, Jun-Ying Ma, Yan-Wei Wang, Su-Shuang Lu

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC women's health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Bao-Jie FengDepartment of Gynecology, the Fourth Hospital of Hebei Medical University, No.12 of Jian-kang Road, Chang-an District, Shijiazhuang, 050011, China.
Tian-Hua LiDepartment of Gynecology, the Fourth Hospital of Hebei Medical University, No.12 of Jian-kang Road, Chang-an District, Shijiazhuang, 050011, China.
Yue-Hong LiDepartment of Pathology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
Jing-Xuan FengDepartment of Clinical Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
Jun ZhangDepartment of Gynecology, the Fourth Hospital of Hebei Medical University, No.12 of Jian-kang Road, Chang-an District, Shijiazhuang, 050011, China.
Jun-Ying MaDepartment of Gynecology, the Fourth Hospital of Hebei Medical University, No.12 of Jian-kang Road, Chang-an District, Shijiazhuang, 050011, China. mayingjumyj8@126.com.
Yan-Wei WangDepartment of Gynecology, the Fourth Hospital of Hebei Medical University, No.12 of Jian-kang Road, Chang-an District, Shijiazhuang, 050011, China.
Su-Shuang LuDepartment of Gynecology, The First Hospital of Hebei Medical University, Shijiazhuang, 050032, China.
Fourth Hospital of Hebei Medical University · CNHebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOvarian neuroendocrine carcinoma (O-NEC) is a relatively uncommon neoplasm, and the current knowledge regarding its diagnosis and management is limited. In this series, our objective was to provide an overview of the clinicopathological characteristics of the disease by analyzing clinical case data to establish a theoretical foundation for the diagnosis and management of O-NEC. CASE PRESENTATION: We included three patients in the present case series, all of whom were diagnosed with primary O-NEC based on pathomorphological observation and immunohistochemistry. Patient 1 was a 62-year-old patient diagnosed with small cell carcinoma (SCC) of the pulmonary type. Post-surgery, the patient was diagnosed with stage II SCC of the ovary and underwent standardized chemotherapy; however, imaging examinations conducted at the 16-month follow-up revealed the existence of lymph node metastasis. Unfortunately, she passed away 21 months after the surgery. The other two patients were diagnosed with carcinoid tumors, one at age 39 and the other at age 71. Post-surgery, patient 2 was diagnosed with a carcinoid in the left ovary, whereas patient 3 was diagnosed with a carcinoid in her right ovary based on clinical evaluation. Neither of the cases received adjuvant therapy following surgery; however, they have both survived for 9 and 10 years, respectively, as of date.

conclusionPrimary O-NECs are rare and of diverse histological types, each of which has its own unique biological features and prognosis. SCC is a neoplasm characterized by high malignancy and a poor prognosis, whereas carcinoid tumors are of lesser malignancy and have a more favorable prognosis.

Indexed as

Carcinoid TumorCarcinoma, NeuroendocrineCarcinoma, Small CellNeuroendocrine TumorsOvarian NeoplasmsAdultAgedCarcinoma, Ovarian EpithelialFemaleHumansMiddle AgedPrognosisImmunohistochemistryNeuroendocrine carcinomaOvaryPathological characteristicsPrognosis

Identifiers

PMID37953251
PMCPMC10641945
OpenAlexW4388616046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.